Skip to content

Neurelis is a pharmaceutical company founded in 2007, focused on developing and commercializing therapies for central nervous system disorders.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Neurelis was founded in 2007 with a vow to provide progressive solutions in therapeutic care to address unmet needs. The company was formed in San Diego to address unmet needs for central nervous system disorders. It licenses, develops, and commercializes product candidates for the broader central nervous system (CNS), including epilepsy and psychiatry. Neurelis has developed technologies such as Intravail® and ProTek® to enhance drug delivery and stability.

History

Neurelis was founded in 2007 with a vow to provide progressive solutions in therapeutic care to address unmet needs. It was formed in San Diego to address unmet needs for central nervous system disorders. The company licensed Intravail® absorption enhancement technology from Aegis Therapeutics, LLC. Over time, it explored various formulations, initiated clinical trials, received orphan drug designation and fast track designation from the FDA, filed a New Drug Application, and acquired Aegis Therapeutics, LLC.

Recent events

  • Reported

    Neurelis partners with Rick Harrison on epilepsy education[6]

    Neurelis announced a partnership with epilepsy education advocate Rick Harrison to raise awareness of epilepsy and the need for more education regarding seizure emergencies. The initiatives include Harrison meeting with physicians and community members and filming informational videos for distribution via social media in 2022.

  • Reported

    Neurelis completes term loan facility from OrbiMed[7]

    Neurelis announced that it completed a senior term loan facility of up to $150 million from OrbiMed to support commercialization of VALTOCO, pipeline development and potential strategic opportunities.

Read more

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/neurelis · Editorial policy · How profiles are compiled